U.S. Neurology Associates
PrivateLast Round
Growth Equity
Jan 9, 2026
Momentum
Top 50%
of companies Caplight tracks
Company Overview
U.S. Neurology Associates is a healthcare services company that provides administrative, operational, and strategic support to community-based neurology practices to enhance patient care and practice growth.
Sector
Healthcare & Life Sciences
Verticals
Vertical SaaS, Revenue Cycle, Medical Imaging, Clinical Trials, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
U.S. Neurology Associates Comparables
Compare U.S. Neurology Associates with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Autonomy Health | 88% | |
| PracticeCore | 76% | |
| United Musculoskeletal Partners | 68% |
U.S. Neurology Associates Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Jan 9, 2026 |
U.S. Neurology Associates Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| M33 Growth | Growth Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 9, 2026
Raised Growth Equity round led by M33 Growth.
U.S. Neurology Associates Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access